AG
NUVA

Aperio Group’s NuVasive, Inc. NUVA Stock Holding History

Aperio Group’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$339K Sell
6,032
-951
-14% -$46.8K ﹤0.01% 2127
2020
Q3 		$340K Sell
6,983
-2,217
-24% -$119K ﹤0.01% 2014
2020
Q2 		$512K Sell
9,200
-1,080
-11% -$62.5K ﹤0.01% 1767
2020
Q1 		$520K Buy
10,280
+1,235
+14% +$82.8K ﹤0.01% 1628
2019
Q4 		$700K Buy
9,045
+358
+4% +$25.3K ﹤0.01% 1630
2019
Q3 		$551K Buy
8,687
+1,016
+13% +$63.5K ﹤0.01% 1705
2019
Q2 		$449K Sell
7,671
-539
-7% -$31.8K ﹤0.01% 1846
2019
Q1 		$466K Sell
8,210
-1,914
-19% -$102K ﹤0.01% 1787
2018
Q4 		$501K Buy
10,124
+568
+6% +$34.2K ﹤0.01% 1676
2018
Q3 		$678K Sell
9,556
-673
-7% -$42.8K ﹤0.01% 1614
2018
Q2 		$533K Sell
10,229
-656
-6% -$34.4K ﹤0.01% 1714
2018
Q1 		$569K Sell
10,885
-653
-6% -$33.1K ﹤0.01% 1635
2017
Q4 		$675K Buy
11,538
+1,265
+12% +$71.7K ﹤0.01% 1548
2017
Q3 		$569K Sell
10,273
-924
-8% -$61.1K ﹤0.01% 1594
2017
Q2 		$862K Buy
11,197
+750
+7% +$56.1K 0.01% 1313
2017
Q1 		$781K Buy
10,447
+1,350
+15% +$98K 0.01% 1283
2016
Q4 		$613K Buy
9,097
+733
+9% +$47.2K ﹤0.01% 1393
2016
Q3 		$558K Buy
8,364
+168
+2% +$10.7K ﹤0.01% 1385
2016
Q2 		$489K Buy
8,196
+655
+9% +$35.4K ﹤0.01% 1396
2016
Q1 		$367K Buy
7,541
+753
+11% +$34.2K ﹤0.01% 1532
2015
Q4 		$367K Buy
6,788
+813
+14% +$41.5K ﹤0.01% 1507
2015
Q3 		$288K Buy
5,975
+32
+0.5% +$1.65K ﹤0.01% 1581
2015
Q2 		$282K Buy
5,943
+43
+0.7% +$2.01K ﹤0.01% 1671
2015
Q1 		$271K Buy
5,900
+957
+19% +$44.5K ﹤0.01% 1640
2014
Q4 		$233K Buy
+4,943
New +$206K ﹤0.01% 1655

Other funds holding NUVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Aperio Group's NUVA Position: Q4 2020 in Review

Aperio Group reduced its NuVasive, Inc. (NUVA) stake by 14% in Q4 2020, selling an estimated $46.8K and leaving 6,032 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #2127.

Aperio Group first reported a position in NUVA in Q4 2014 and has held it in 25 quarters since. The position peaked at $862K in Q2 2017. 280 funds tracked by Wall St. Rank hold NUVA as of Q4 2020.

  • Aperio Group held 6,032 shares of NuVasive, Inc. worth $339K as of Q4 2020.
  • Aperio Group sold 951 NuVasive, Inc. shares in Q4 2020, an estimated $46.8K.
  • NuVasive, Inc. made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2127 holding.
  • Aperio Group first reported a position in NuVasive, Inc. in Q4 2014 and has held it in 25 quarters since.
  • Aperio Group's NuVasive, Inc. position peaked at $862K in Q2 2017.
  • 280 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.